P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY
O. Albanyan,
O. Castaneda-Puglianini,
J. Chavez
Affiliations
O. Albanyan
1 Blood and Marrow Transplant and Cellular Immunotherapy
O. Castaneda-Puglianini
1 Blood and Marrow Transplant and Cellular Immunotherapy
J. Chavez
2 Department of Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America
